Click for best price
Biopharmaceuticals Market Size, Share 2023
| Market size in 2022 |
US$ 33340 million
|
Forecast Market size by 2029 |
US$ 55870 million
|
| Growth Rate |
CAGR of 7.7% |
Number of Pages |
113 Pages |
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources?human, animal, plant, fungal, or microbial.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals. This report contains market size and forecasts of Biopharmaceuticals in global, including the following market information:
Global top five companies in 2022 (%)
The global Biopharmaceuticals market was valued at US$ 33340 million in 2022 and is projected to reach US$ 55870 million by 2029, at a CAGR of 7.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
- Monoclonal Antibodies
- Interferon
- Colony-Stimulating Factor
- Erythropoietin
- Insulin
- Vaccines
- Growth Hormones
- Others
Global Biopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
Global Biopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biopharmaceuticals revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biopharmaceuticals revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- Sun
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
- SANDOZ (NOVARTIS)
- Teva Pharmaceutical
- Hospira ?Pfizer?
- MYLAN
- Sun pharma
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biopharmaceuticals, market overview.
- Chapter 2: Global Biopharmaceuticals market size in revenue.
- Chapter 3: Detailed analysis of Biopharmaceuticals company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biopharmaceuticals Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 33340 million
|
| Forecast Market size by 2029 |
US$ 55870 million
|
| Growth Rate |
CAGR of 7.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceuticals Overall Market Size
2.1 Global Biopharmaceuticals Market Size: 2022 VS 2029
2.2 Global Biopharmaceuticals Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceuticals Players in Global Market
3.2 Top Global Biopharmaceuticals Companies Ranked by Revenue
3.3 Global Biopharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceuticals Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biopharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceuticals Players in Global Market
3.6.1 List of Global Tier 1 Biopharmaceuticals Companies
3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceuticals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biopharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Colony-Stimulating Factor
4.1.5 Erythropoietin
4.1.6 Insulin
4.1.7 Vaccines
4.1.8 Growth Hormones
4.1.9 Others
4.2 By Type - Global Biopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Biopharmaceuticals Revenue, 2018-2023
4.2.2 By Type - Global Biopharmaceuticals Revenue, 2024-2029
4.2.3 By Type - Global Biopharmaceuticals Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biopharmaceuticals Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Biopharmaceuticals Revenue, 2018-2023
5.2.2 By Application - Global Biopharmaceuticals Revenue, 2024-2029
5.2.3 By Application - Global Biopharmaceuticals Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biopharmaceuticals Market Size, 2022 & 2029
6.2 By Region - Global Biopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Biopharmaceuticals Revenue, 2018-2023
6.2.2 By Region - Global Biopharmaceuticals Revenue, 2024-2029
6.2.3 By Region - Global Biopharmaceuticals Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biopharmaceuticals Revenue, 2018-2029
6.3.2 US Biopharmaceuticals Market Size, 2018-2029
6.3.3 Canada Biopharmaceuticals Market Size, 2018-2029
6.3.4 Mexico Biopharmaceuticals Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biopharmaceuticals Revenue, 2018-2029
6.4.2 Germany Biopharmaceuticals Market Size, 2018-2029
6.4.3 France Biopharmaceuticals Market Size, 2018-2029
6.4.4 U.K. Biopharmaceuticals Market Size, 2018-2029
6.4.5 Italy Biopharmaceuticals Market Size, 2018-2029
6.4.6 Russia Biopharmaceuticals Market Size, 2018-2029
6.4.7 Nordic Countries Biopharmaceuticals Market Size, 2018-2029
6.4.8 Benelux Biopharmaceuticals Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biopharmaceuticals Revenue, 2018-2029
6.5.2 China Biopharmaceuticals Market Size, 2018-2029
6.5.3 Japan Biopharmaceuticals Market Size, 2018-2029
6.5.4 South Korea Biopharmaceuticals Market Size, 2018-2029
6.5.5 Southeast Asia Biopharmaceuticals Market Size, 2018-2029
6.5.6 India Biopharmaceuticals Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biopharmaceuticals Revenue, 2018-2029
6.6.2 Brazil Biopharmaceuticals Market Size, 2018-2029
6.6.3 Argentina Biopharmaceuticals Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biopharmaceuticals Revenue, 2018-2029
6.7.2 Turkey Biopharmaceuticals Market Size, 2018-2029
6.7.3 Israel Biopharmaceuticals Market Size, 2018-2029
6.7.4 Saudi Arabia Biopharmaceuticals Market Size, 2018-2029
6.7.5 UAE Biopharmaceuticals Market Size, 2018-2029
7 Biopharmaceuticals Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biopharmaceuticals Major Product Offerings
7.1.4 Roche Biopharmaceuticals Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biopharmaceuticals Major Product Offerings
7.2.4 Amgen Biopharmaceuticals Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biopharmaceuticals Major Product Offerings
7.3.4 AbbVie Biopharmaceuticals Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Company Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biopharmaceuticals Major Product Offerings
7.4.4 Sanofi-Aventis Biopharmaceuticals Revenue in Global Market (2018-2023)
7.4.5 Sanofi-Aventis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biopharmaceuticals Major Product Offerings
7.5.4 Johnson & Johnson Biopharmaceuticals Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biopharmaceuticals Major Product Offerings
7.6.4 Pfizer Biopharmaceuticals Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biopharmaceuticals Major Product Offerings
7.7.4 Novo Nordisk Biopharmaceuticals Revenue in Global Market (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biopharmaceuticals Major Product Offerings
7.8.4 Eli Lilly Biopharmaceuticals Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biopharmaceuticals Major Product Offerings
7.9.4 Novartis Biopharmaceuticals Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biopharmaceuticals Major Product Offerings
7.10.4 Merck Biopharmaceuticals Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 Sun
7.11.1 Sun Company Summary
7.11.2 Sun Business Overview
7.11.3 Sun Biopharmaceuticals Major Product Offerings
7.11.4 Sun Biopharmaceuticals Revenue in Global Market (2018-2023)
7.11.5 Sun Key News & Latest Developments
7.12 3sbio
7.12.1 3sbio Company Summary
7.12.2 3sbio Business Overview
7.12.3 3sbio Biopharmaceuticals Major Product Offerings
7.12.4 3sbio Biopharmaceuticals Revenue in Global Market (2018-2023)
7.12.5 3sbio Key News & Latest Developments
7.13 Changchun High Tech
7.13.1 Changchun High Tech Company Summary
7.13.2 Changchun High Tech Business Overview
7.13.3 Changchun High Tech Biopharmaceuticals Major Product Offerings
7.13.4 Changchun High Tech Biopharmaceuticals Revenue in Global Market (2018-2023)
7.13.5 Changchun High Tech Key News & Latest Developments
7.14 CP Guojian
7.14.1 CP Guojian Company Summary
7.14.2 CP Guojian Business Overview
7.14.3 CP Guojian Biopharmaceuticals Major Product Offerings
7.14.4 CP Guojian Biopharmaceuticals Revenue in Global Market (2018-2023)
7.14.5 CP Guojian Key News & Latest Developments
7.15 Biotech
7.15.1 Biotech Company Summary
7.15.2 Biotech Business Overview
7.15.3 Biotech Biopharmaceuticals Major Product Offerings
7.15.4 Biotech Biopharmaceuticals Revenue in Global Market (2018-2023)
7.15.5 Biotech Key News & Latest Developments
7.16 Gelgen
7.16.1 Gelgen Company Summary
7.16.2 Gelgen Business Overview
7.16.3 Gelgen Biopharmaceuticals Major Product Offerings
7.16.4 Gelgen Biopharmaceuticals Revenue in Global Market (2018-2023)
7.16.5 Gelgen Key News & Latest Developments
7.17 Innovent
7.17.1 Innovent Company Summary
7.17.2 Innovent Business Overview
7.17.3 Innovent Biopharmaceuticals Major Product Offerings
7.17.4 Innovent Biopharmaceuticals Revenue in Global Market (2018-2023)
7.17.5 Innovent Key News & Latest Developments
7.18 Dong Bao
7.18.1 Dong Bao Company Summary
7.18.2 Dong Bao Business Overview
7.18.3 Dong Bao Biopharmaceuticals Major Product Offerings
7.18.4 Dong Bao Biopharmaceuticals Revenue in Global Market (2018-2023)
7.18.5 Dong Bao Key News & Latest Developments
7.19 Ganlee
7.19.1 Ganlee Company Summary
7.19.2 Ganlee Business Overview
7.19.3 Ganlee Biopharmaceuticals Major Product Offerings
7.19.4 Ganlee Biopharmaceuticals Revenue in Global Market (2018-2023)
7.19.5 Ganlee Key News & Latest Developments
7.20 United Laboratories
7.20.1 United Laboratories Company Summary
7.20.2 United Laboratories Business Overview
7.20.3 United Laboratories Biopharmaceuticals Major Product Offerings
7.20.4 United Laboratories Biopharmaceuticals Revenue in Global Market (2018-2023)
7.20.5 United Laboratories Key News & Latest Developments
7.21 SANDOZ (NOVARTIS)
7.21.1 SANDOZ (NOVARTIS) Company Summary
7.21.2 SANDOZ (NOVARTIS) Business Overview
7.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Major Product Offerings
7.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue in Global Market (2018-2023)
7.21.5 SANDOZ (NOVARTIS) Key News & Latest Developments
7.22 Teva Pharmaceutical
7.22.1 Teva Pharmaceutical Company Summary
7.22.2 Teva Pharmaceutical Business Overview
7.22.3 Teva Pharmaceutical Biopharmaceuticals Major Product Offerings
7.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue in Global Market (2018-2023)
7.22.5 Teva Pharmaceutical Key News & Latest Developments
7.23 Hospira ?Pfizer?
7.23.1 Hospira ?Pfizer? Company Summary
7.23.2 Hospira ?Pfizer? Business Overview
7.23.3 Hospira ?Pfizer? Biopharmaceuticals Major Product Offerings
7.23.4 Hospira ?Pfizer? Biopharmaceuticals Revenue in Global Market (2018-2023)
7.23.5 Hospira ?Pfizer? Key News & Latest Developments
7.24 MYLAN
7.24.1 MYLAN Company Summary
7.24.2 MYLAN Business Overview
7.24.3 MYLAN Biopharmaceuticals Major Product Offerings
7.24.4 MYLAN Biopharmaceuticals Revenue in Global Market (2018-2023)
7.24.5 MYLAN Key News & Latest Developments
7.25 Sun pharma
7.25.1 Sun pharma Company Summary
7.25.2 Sun pharma Business Overview
7.25.3 Sun pharma Biopharmaceuticals Major Product Offerings
7.25.4 Sun pharma Biopharmaceuticals Revenue in Global Market (2018-2023)
7.25.5 Sun pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biopharmaceuticals Market Opportunities & Trends in Global Market
Table 2. Biopharmaceuticals Market Drivers in Global Market
Table 3. Biopharmaceuticals Market Restraints in Global Market
Table 4. Key Players of Biopharmaceuticals in Global Market
Table 5. Top Biopharmaceuticals Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biopharmaceuticals Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biopharmaceuticals Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biopharmaceuticals Product Type
Table 9. List of Global Tier 1 Biopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biopharmaceuticals Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biopharmaceuticals Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biopharmaceuticals Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biopharmaceuticals Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Biopharmaceuticals Product Offerings
Table 32. Roche Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Biopharmaceuticals Product Offerings
Table 36. Amgen Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. AbbVie Company Summary
Table 39. AbbVie Biopharmaceuticals Product Offerings
Table 40. AbbVie Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 41. AbbVie Key News & Latest Developments
Table 42. Sanofi-Aventis Company Summary
Table 43. Sanofi-Aventis Biopharmaceuticals Product Offerings
Table 44. Sanofi-Aventis Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi-Aventis Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Biopharmaceuticals Product Offerings
Table 48. Johnson & Johnson Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Biopharmaceuticals Product Offerings
Table 52. Pfizer Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Novo Nordisk Company Summary
Table 55. Novo Nordisk Biopharmaceuticals Product Offerings
Table 56. Novo Nordisk Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 57. Novo Nordisk Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Biopharmaceuticals Product Offerings
Table 60. Eli Lilly Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Biopharmaceuticals Product Offerings
Table 64. Novartis Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Biopharmaceuticals Product Offerings
Table 68. Merck Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Key News & Latest Developments
Table 70. Sun Company Summary
Table 71. Sun Biopharmaceuticals Product Offerings
Table 72. Sun Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 73. Sun Key News & Latest Developments
Table 74. 3sbio Company Summary
Table 75. 3sbio Biopharmaceuticals Product Offerings
Table 76. 3sbio Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 77. 3sbio Key News & Latest Developments
Table 78. Changchun High Tech Company Summary
Table 79. Changchun High Tech Biopharmaceuticals Product Offerings
Table 80. Changchun High Tech Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 81. Changchun High Tech Key News & Latest Developments
Table 82. CP Guojian Company Summary
Table 83. CP Guojian Biopharmaceuticals Product Offerings
Table 84. CP Guojian Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 85. CP Guojian Key News & Latest Developments
Table 86. Biotech Company Summary
Table 87. Biotech Biopharmaceuticals Product Offerings
Table 88. Biotech Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 89. Biotech Key News & Latest Developments
Table 90. Gelgen Company Summary
Table 91. Gelgen Biopharmaceuticals Product Offerings
Table 92. Gelgen Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 93. Gelgen Key News & Latest Developments
Table 94. Innovent Company Summary
Table 95. Innovent Biopharmaceuticals Product Offerings
Table 96. Innovent Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 97. Innovent Key News & Latest Developments
Table 98. Dong Bao Company Summary
Table 99. Dong Bao Biopharmaceuticals Product Offerings
Table 100. Dong Bao Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 101. Dong Bao Key News & Latest Developments
Table 102. Ganlee Company Summary
Table 103. Ganlee Biopharmaceuticals Product Offerings
Table 104. Ganlee Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 105. Ganlee Key News & Latest Developments
Table 106. United Laboratories Company Summary
Table 107. United Laboratories Biopharmaceuticals Product Offerings
Table 108. United Laboratories Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 109. United Laboratories Key News & Latest Developments
Table 110. SANDOZ (NOVARTIS) Company Summary
Table 111. SANDOZ (NOVARTIS) Biopharmaceuticals Product Offerings
Table 112. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 113. SANDOZ (NOVARTIS) Key News & Latest Developments
Table 114. Teva Pharmaceutical Company Summary
Table 115. Teva Pharmaceutical Biopharmaceuticals Product Offerings
Table 116. Teva Pharmaceutical Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 117. Teva Pharmaceutical Key News & Latest Developments
Table 118. Hospira ?Pfizer? Company Summary
Table 119. Hospira ?Pfizer? Biopharmaceuticals Product Offerings
Table 120. Hospira ?Pfizer? Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 121. Hospira ?Pfizer? Key News & Latest Developments
Table 122. MYLAN Company Summary
Table 123. MYLAN Biopharmaceuticals Product Offerings
Table 124. MYLAN Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 125. MYLAN Key News & Latest Developments
Table 126. Sun pharma Company Summary
Table 127. Sun pharma Biopharmaceuticals Product Offerings
Table 128. Sun pharma Biopharmaceuticals Revenue (US$, Mn) & (2018-2023)
Table 129. Sun pharma Key News & Latest Developments
List of Figures
Figure 1. Biopharmaceuticals Segment by Type in 2022
Figure 2. Biopharmaceuticals Segment by Application in 2022
Figure 3. Global Biopharmaceuticals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biopharmaceuticals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biopharmaceuticals Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceuticals Revenue in 2022
Figure 8. By Type - Global Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 16. US Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 20. Germany Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 21. France Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 28. China Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 32. India Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 34. Brazil Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biopharmaceuticals Revenue Market Share, 2018-2029
Figure 37. Turkey Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AbbVie Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi-Aventis Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novo Nordisk Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novartis Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sun Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. 3sbio Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Changchun High Tech Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CP Guojian Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Biotech Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Gelgen Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Innovent Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Dong Bao Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Ganlee Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. United Laboratories Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Teva Pharmaceutical Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Hospira ?Pfizer? Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. MYLAN Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Sun pharma Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
